Obesity-related hypertension: Is there a role for selective leptin resistance?
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Obesity is a risk factor for cardiovascular diseases, in particular for hypertension. Serum leptin levels and sympathetic nerve activity are both increased in obesity. Leptin has been demonstrated to increase sympathetic nerve activity. Thus, leptin-dependent sympathoactivation might contribute to obesity-related hypertension. However, leptin resistance occurs in obesity. One possibility is that leptin resistance is selective to the metabolic effects of leptin, sparing its sympathoexcitatory actions. In this article, we review experimental evidence supporting the novel concept of selective leptin resistance. We also discuss the sympathetic actions of leptin that are relevant to blood pressure modulation and potential mechanisms of leptin resistance. Disruption of leptin intracellular signaling pathways and resistance of specific leptin-responsive neural networks provide theoretic models of selective leptin resistance. However, most information about leptin-sympathetic actions and leptin-resistance mechanisms derive from in vitro and animal studies. Future research in humans is widely awaited.
References and Recommended Reading
Haynes WG, Morgan DA, Walsh SA, et al.: Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest 1997, 100:270–278.PubMed
Shek EW, Brands MW, Hall JE: Chronic leptin infusion increases arterial pressure. Hypertension 1998, 31:409–414.PubMed
Correia ML, Morgan DA, Sivitz WI, et al.: Leptin acts in the central nervous system to produce dose-dependent changes in arterial pressure. Hypertension 2001, 37:936–942.PubMed
Aizawa-Abe M, Ogawa Y, Masuzaki H, et al.: Pathophysiological role of leptin in obesity-related hypertension. J Clin Invest 2000, 105:1243–1252. This is an important manuscript showing that hypertension in transgenic skinny mice overexpressing leptin is likely due to sympathetic activation. In addition, it is shown that leptin contributes to blood pressure control in obese agouti mice, despite leptin resistance.PubMed
El-Haschimi K, Pierroz DD, Hileman SM, et al.: Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J Clin Invest 2000, 105:1827–1832.PubMed
Correia ML, Haynes WG, Rahmouni K, et al.: The concept of selective leptin resistance: evidence from agouti yellow obese mice. Diabetes 2002, 51:439–442. This interesting manuscript formally introduces the novel concept of selective leptin resistance by showing that leptin-induced sympathoactivation is preserved in leptin-resistant obese agouti mice.PubMedCrossRef
Rahmouni K, Haynes WG, Morgan DA, Mark AL: Selective resistance to central neural administration of leptin in agouti obese mice. Hypertension 2002, 39:486–490. This manuscript shows that selective leptin resistance is not caused by systemic effects of leptin on the sympathetic nervous system. Leptin-dependent sympathoactivation is preserved after intracerebral administration of leptin to agouti obese mice that exhibit metabolic leptin resistance.PubMedCrossRef
Steinberg GR, Parolin ML, Heigenhauser GJ, Dyck DJ: Leptin increases FA oxidation in lean but not obese human skeletal muscle: evidence of peripheral leptin resistance. Am J Physiol Endocrinol Metab 2002, 283:E187-E192. This important manuscript shows, for the first time, biochemical evidence of leptin resistance in human skeletal muscle tissue.PubMed
Morgan DA, Rahmouni K, Mark AL, et al.: Selective leptin resistance during high fat diet in mice: preservation sympathetic activation despite attenuation of metabolic responses [abstract]. Hypertension 2001, 38:34.
Rahmouni K, Morgan DA, Morgan GM, et al.: Renal-specific preservation of sympathoexcitatory effect of leptin in dietinduced obese mice [abstract]. Hypertension 2003, 42:421.
Haynes WG, Morgan DA, Djalali A, et al.: Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic. Hypertension 1999, 33:542–547.PubMed
Correia ML, Morgan DA, Mitchell JL, et al.: Role of corticotrophin-releasing factor in effects of leptin on sympathetic nerve activity and arterial pressure. Hypertension 2001, 38:384–388.PubMed
Grassi G, Seravalle G, Cattaneo BM, et al.: Sympathetic activation in obese normotensive subjects. Hypertension 1995, 25:560–563.PubMed
Matsubara M, Chiba H, Maruoka S, Katayose S: Elevated serum leptin concentrations in women with components of multiple risk factor clustering syndrome. J Atheroscler Thromb 2000, 7:231–237.PubMed
Snitker S, Pratley RE, Nicolson M, et al.: Relationship between muscle sympathetic nerve activity and plasma leptin concentration. Obes Res 1997, 5:338–340.PubMed
- Obesity-related hypertension: Is there a role for selective leptin resistance?
Current Hypertension Reports
Volume 6, Issue 3 , pp 230-235
- Cover Date
- Print ISSN
- Online ISSN
- Current Medicine Group
- Additional Links
- Industry Sectors